We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Colorimetric Test Devised for Tuberculosis in Developing Areas

By LabMedica International staff writers
Posted on 28 Dec 2015
Print article
The ND-1000 spectrophotometer
The ND-1000 spectrophotometer (Photo courtesy of NANODROP TECHNOLOGIES)
A rapid, sensitive and low-cost method has been devised for detecting tuberculosis (TB), a highly infectious disease and a major global health problem, especially in countries with developing health care systems.

The typical way that physicians screen for TB, which is caused by the bacterium Mycobacterium tuberculosis (Mtb), is with a tuberculin skin test or an examination of a patient's sputum under a microscope. To weed out false positives, a more reliable test that involves growing Mtb cultures can be performed, but that requires weeks to complete.

Scientists at the Australian Institute for Bioengineering and Nanotechnology (St Lucia, QLD, Australia) and their colleagues began with a newly created nucleic acid amplification test that does not require expensive laboratory equipment to detect Mtb, but this modified test typically uses costly fluorescence technology to read the results. The team substituted the fluorescence detector with a colorimetric assay that changes to a blue hue if the infection is present, allowing health care workers to identify positive test results right away with the naked eye.

The team employed a modified Solid Phase Reversible Immobilization (SPRI) protocol) with Guanidium-HCl lysis buffer to sample for genomic DNA (gDNA) from Mtb cells. Nucleic acid amplification was performed with the TwistAmp Basic RPA Kit (TwistDx Limited; Cambridge, UK). They devised a simple colorimetric assay that utilizes the chemical oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB) by isothermally functionalized DNA targets as a sensitive and specific biosensor for the detection of tuberculosis. Absorbance was determined with the ND-1000spectrophotometer (NanoDrop; Wilmington, DE, USA). Ampometry responses were measured on a workstation potentiostat (CH Instruments; Austin, TX, USA).

The team demonstrated how the modified diagnostic could be put on cheap, disposable electrochemical sensors for increased sensitivity, even in the field. Because the assay is inexpensive, quick and highly specific for the Mtb bacterium, the scientists say it could have a big impact in low-resource communities. The assays are inexpensive at USD 3.00, takes only 75 minutes, sensitive as approaching a single cell, and highly specific to M. tuberculosis. The study was published on November 30, 2015, in the journal ACS Sensors.

Related Links:

Australian Institute for Bioengineering and Nanotechnology 
TwistDx Limited 
NanoDrop


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Silver Member
ACTH Assay
ACTH ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.